Breast cancer treatment and its effects on aging

Siegel, 2017, Cancer statistics, 2017, CA Cancer J Clin, 67, 7, 10.3322/caac.21387 López-Otín, 2013, The hallmarks of aging, Cell, 153, 1194, 10.1016/j.cell.2013.05.039 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Reimer, 2010, Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly, Drugs Aging, 27, 791, 10.2165/11584700-000000000-00000 Cohen, 2012, Impact of age, comorbidity and symptoms on physical function in long-term breast cancer survivors (CALGB 70803), J Geriatr Oncol, 3, 10.1016/j.jgo.2012.01.005 Smith, 2009, Race/ethnicity, physical activity, and quality of life in breast cancer survivors, Cancer Epidemiol Biomarkers Prev, 18, 656, 10.1158/1055-9965.EPI-08-0352 Wampler, 2007, Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy, Arch Phys Med Rehabil, 88, 1002, 10.1016/j.apmr.2007.05.007 Von Ah, 2009, Cognitive dysfunction and its relationship to quality of life in breast cancer survivors, Oncol Nurs Forum, 36, 326, 10.1188/09.ONF.326-334 Paraskevi, 2012, Quality of life outcomes in patients with breast cancer, Oncol Rev, 6, 10.4081/oncol.2012.e2 Rowland, 2014, Cancer survivorship issues: life after treatment and implications for an aging population, J Clin Oncol, 32, 2662, 10.1200/JCO.2014.55.8361 Ciambrone, 2006, Treatment decision-making among older women with breast cancer, J Women Aging, 18, 31, 10.1300/J074v18n04_04 Puts, 2015, A systematic review of factors influencing older adults' decision to accept or decline cancer treatment, Cancer Treat Rev, 41, 197, 10.1016/j.ctrv.2014.12.010 Turner, 2017, Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity, Nature, 543, 122, 10.1038/nature21356 Tidwell, 2017, Aging, Metabolism, and Cancer Development: from Peto's Paradox to the Warburg Effect, Aging Dis, 8, 662, 10.14336/AD.2017.0713 de Magalhaes, 2013, How ageing processes influence cancer, Nat Rev Cancer, 13, 357, 10.1038/nrc3497 Torino, 2014, Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer, Crit Rev Oncol Hematol, 89, 27, 10.1016/j.critrevonc.2013.07.007 Shadyab, 2017, Ages at menarche and menopause and reproductive lifespan as predictors of exceptional longevity in women: the Women's Health Initiative, Menopause, 24, 35, 10.1097/GME.0000000000000710 Peel, 2014, Cardiorespiratory fitness in breast cancer patients: a call for normative values, J Am Heart Assoc, 3, e000432, 10.1161/JAHA.113.000432 Zambetti, 2001, Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation, J Clin Oncol, 19, 37, 10.1200/JCO.2001.19.1.37 Ganz, 2008, Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897, J Clin Oncol, 26, 1223, 10.1200/JCO.2007.11.8877 Doyle, 2005, Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study, J Clin Oncol, 23, 8597, 10.1200/JCO.2005.02.5841 Gianni, 2008, Anthracycline cardiotoxicity: from bench to bedside, J Clin Oncol, 26, 3777, 10.1200/JCO.2007.14.9401 Pinder, 2007, Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer, J Clin Oncol, 25, 3808, 10.1200/JCO.2006.10.4976 Bouvard, 2014, Fracture incidence after 3 years of aromatase inhibitor therapy, Ann Oncol, 25, 843, 10.1093/annonc/mdu008 Vanderwalde, 2011, Aging and osteoporosis in breast and prostate cancer, A Cancer J Clin, 61, 139, 10.3322/caac.20103 Brufsky, 2008, Cancer treatment-induced bone loss: pathophysiology and clinical perspectives, Oncologist, 13, 187, 10.1634/theoncologist.2007-0152 Balducci, 2010, Bone complications of cancer treatment in the elderly, Oncology (Williston Park), 24, 741 Ward, 2014, Fall-related injuries in elderly cancer patients treated with neurotoxic chemotherapy: a retrospective cohort study, J Geriatr Oncol, 5, 57, 10.1016/j.jgo.2013.10.002 Vardy, 2009, Cognitive function in breast cancer survivors, Cancer Treat Res, 151, 387, 10.1007/978-0-387-75115-3_24 Janelsins, 2014, Prevalence, mechanisms, and management of cancer-related cognitive impairment, Int Rev Psychiatry, 26, 102, 10.3109/09540261.2013.864260 Wefel, 2015, Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults, CA Cancer J Clin, 65, 123, 10.3322/caac.21258 Ahles, 2012, Cancer- and cancer treatment-associated cognitive change: an update on the state of the science, J Clin Oncol, 30, 3675, 10.1200/JCO.2012.43.0116 Koppelmans, 2012, Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy, J Clin Oncol, 30, 1080, 10.1200/JCO.2011.37.0189 Wefel, 2010, Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer, Cancer, 116, 3348, 10.1002/cncr.25098 Conroy SK, McDonald BC, Smith DJ, Moser LR, West JD, Kamendulis LM, Klaunig JE, Champion VL, Unverzagt FW, Saykin AJ. Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast cancer research and treatment. 2013;137(2):493–502. doi: https://doi.org/10.1007/s10549-012-2385-x. (PubMed PMID: 23263697; PMCID: PMC3543695). de Ruiter, 2011, Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer, Hum Brain Mapp, 32, 1206, 10.1002/hbm.21102 Kesler, 2011, Prefrontal cortex and executive function impairments in primary breast cancer, Arch Neurol, 68, 10.1001/archneurol.2011.245 Kesler, 2015, Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer, Neurobiol Aging, 36, 2429, 10.1016/j.neurobiolaging.2015.04.015 Lange, 2014, Baseline cognitive functions among elderly patients with localised breast cancer, Eur J Cancer, 50, 2181, 10.1016/j.ejca.2014.05.026 Mandelblatt, 2014, Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?, J Clin Oncol, 32, 1909, 10.1200/JCO.2013.54.2050 Von Ah, 2009, Cognitive function in breast cancer survivors compared to healthy age- and education-matched women, 23, 661 Ahles, 2010, Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve, J Clin Oncol, 28, 4434, 10.1200/JCO.2009.27.0827 Collins, 2013, Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy, J Int Neuropsychol Soc, 20, 370, 10.1017/S1355617713001215 Lepage, 2014, A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients, SpringerPlus, 3, 444, 10.1186/2193-1801-3-444 Mandelblatt, 2016, Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance), Cancer, 122, 3555, 10.1002/cncr.30208 Schagen, 2006, Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients, J Natl Cancer Inst, 98, 10.1093/jnci/djj470 Schilder, 2010, Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial, J Clin Oncol, 28, 1294, 10.1200/JCO.2008.21.3553 Jim, 2012, Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy, J Clin Oncol, 30, 3578, 10.1200/JCO.2011.39.5640 Falleti, 2005, The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature, Brain Cogn, 59, 60, 10.1016/j.bandc.2005.05.001 Anderson-Hanley, 2003, Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature, J Int Neuropsychol Soc, 9, 967, 10.1017/S1355617703970019 Jansen, 2005, A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function, Cancer, 104, 2222, 10.1002/cncr.21469 Jansen, 2011, A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients, Support Care Cancer, 19, 1647, 10.1007/s00520-010-0997-4 Ono, 2015, A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer, Front Oncol, 5, 59, 10.3389/fonc.2015.00059 Jenkins, 2006, A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer, Br J Cancer, 94, 828, 10.1038/sj.bjc.6603029 Tager, 2010, The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study, Breast Cancer Res Treat, 123, 25, 10.1007/s10549-009-0606-8 Phillips, 2011, Do aromatase inhibitors have adverse effects on cognitive function?, Breast Cancer Res, 13, 203, 10.1186/bcr2806 Schilder, 2012, Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study, Psychooncology, 21, 479, 10.1002/pon.1928 Castellon, 2004, Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen, J Clin Exp Neuropsychol, 26, 955, 10.1080/13803390490510905 Merriman, 2017, Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer, Psychooncology, 26, 44, 10.1002/pon.4009 Phillips, 2011, Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial, Breast Cancer Res Treat, 126, 10.1007/s10549-010-1235-y Collins, 2009, Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment, Psychooncology, 18, 134, 10.1002/pon.1379 Hermelink, 2007, Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study, Cancer, 109, 10.1002/cncr.22610 Ahles, 2008, Cognitive function in breast cancer patients prior to adjuvant treatment, Breast Cancer Res Treat, 110, 143, 10.1007/s10549-007-9686-5 Mather, 2010, Aging and cognition, Wiley Interdiscip Rev Cogn Sci, 1, 346, 10.1002/wcs.64 Hebert, 2013, Alzheimer disease in the United States (2010–2050) estimated using the 2010 census, Neurology, 80, 1778, 10.1212/WNL.0b013e31828726f5 Lichtman, 2014, Geriatric Oncology: An Overview, J Clin Oncol, 32, 2521, 10.1200/JCO.2014.57.4822 2016 Ehlers, 2016, The intersection of cancer and aging: implications for physical activity and cardiorespiratory fitness effects on cognition, Expert Review of Quality of Life in Cancer Care, 1, 347, 10.1080/23809000.2016.1241661 Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Hurria A, Holland J. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 2006;54(6):925–31. Epub 2006/06/17. doi: https://doi.org/10.1111/j.1532-5415.2006.00732.x. PubMed PMID: 16776787. Ahles, 2012, Cancer- and cancer treatment–associated cognitive change: an update on the state of the science, J Clin Oncol, 30, 3675, 10.1200/JCO.2012.43.0116 Merriman, 2013, Proposed mechanisms for cancer- and treatment-related cognitive. Seminars in oncology nursing, 29 Mandelblatt, 2013, Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?, Semin Oncol, 40, 709, 10.1053/j.seminoncol.2013.09.006 Debess, 2010, Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study, Breast Cancer Res Treat, 121, 91, 10.1007/s10549-010-0756-8 Janelsins, 2017, Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study, J Clin Oncol, 35, 506, 10.1200/JCO.2016.68.5826 Schagen, 2006, Change in Cognitive Function After Chemotherapy: a Prospective Longitudinal Study in Breast Cancer Patients, JNCI, 98, 1742, 10.1093/jnci/djj470 Koppelmans, 2012, Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy, Breast Cancer Res Treat, 132, 1099, 10.1007/s10549-011-1888-1 de Ruiter, 2012, Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging, Hum Brain Mapp, 33, 2971, 10.1002/hbm.21422 Deprez, 2011, Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients, Hum Brain Mapp, 32, 480, 10.1002/hbm.21033 Silverman, 2007, Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy, Breast Cancer Res Treat, 103, 303, 10.1007/s10549-006-9380-z Scherling, 2011, Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study, Front Hum Neurosci, 5, 122, 10.3389/fnhum.2011.00122 Lepage, 2014, A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients, Springerplus, 3, 444, 10.1186/2193-1801-3-444 Blackburn, 2006, Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging, Nat Med, 12, 1133, 10.1038/nm1006-1133 Blasco, 2007, Telomere length, stem cells and aging, Nat Chem Biol, 3, 640, 10.1038/nchembio.2007.38 Blackburn, 2015, Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection, Science, 350, 1193, 10.1126/science.aab3389 Ennour-Idrissi, 2017, Telomere length and breast cancer prognosis: a systematic review, Cancer Epidemiol Biomarkers Prev, 26, 3, 10.1158/1055-9965.EPI-16-0343 Hayashi, 2012, A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest, Nat Struct Mol Biol, 19, 387, 10.1038/nsmb.2245 Bratic, 2013, The role of mitochondria in aging, J Clin Invest, 123, 951, 10.1172/JCI64125 Kraytsberg, 2006, Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons, Nat Genet, 38, 518, 10.1038/ng1778 Ryan, 2007, Mitochondrial-nuclear communications, Annu Rev Biochem, 76, 701, 10.1146/annurev.biochem.76.052305.091720 Holzenberger, 2003, IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice, Nature, 421, 182, 10.1038/nature01298 Bonawitz, 2007, Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression, Cell Metab, 5, 265, 10.1016/j.cmet.2007.02.009 Pavlides, 2009, The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma, Cell Cycle, 8, 3984, 10.4161/cc.8.23.10238 Bonuccelli, 2010, The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts, Cell Cycle, 9, 1960, 10.4161/cc.9.10.11601 Elliott, 2012, Mitochondria organelle transplantation: introduction of normal epithelial mitochondria into human cancer cells inhibits proliferation and increases drug sensitivity, Breast Cancer Res Treat, 136, 347, 10.1007/s10549-012-2283-2 Ma, 2013, Mitochondrial dysfunction promotes breast cancer cell migration and invasion through HIF1alpha accumulation via increased production of reactive oxygen species, PLoS One, 8, e69485, 10.1371/journal.pone.0069485 Kaipparettu, 2013, Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways, PLoS One, 8, e61747, 10.1371/journal.pone.0061747 Stolarek, 2010, Increased H2O2 level in exhaled breath condensate in primary breast cancer patients, J Cancer Res Clin Oncol, 136, 923, 10.1007/s00432-009-0734-x Ray, 2000, Lipid peroxidation, free radical production and antioxidant status in breast cancer, Breast Cancer Res Treat, 59, 163, 10.1023/A:1006357330486 Sehl, 2017, DNA methylation age is elevated in breast tissue of healthy women, Breast Cancer Res Treat, 164, 209, 10.1007/s10549-017-4218-4 Oberdoerffer, 2007, The role of nuclear architecture in genomic instability and ageing, Nat Rev Mol Cell Biol, 8, 692, 10.1038/nrm2238 Vandenberk, 2011, p16INK4a: A central player in cellular senescence and a promising aging biomarker in elderly cancer patients, J Geriatr Oncol, 2, 259, 10.1016/j.jgo.2011.08.004 Liu, 2009, Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging, Aging Cell, 8, 439, 10.1111/j.1474-9726.2009.00489.x Krishnamurthy, 2004, Ink4a/Arf expression is a biomarker of aging, J Clin Invest, 114, 1299, 10.1172/JCI22475 Sanoff, 2014, Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer, J Natl Cancer Inst, 106, dju057, 10.1093/jnci/dju057 Alfano, 2017, Inflammatory cytokines and comorbidity development in breast cancer survivors versus noncancer controls: evidence for accelerated aging?, J Clin Oncol, 35, 149, 10.1200/JCO.2016.67.1883 Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 van de Vijver, 2002, A gene-expression signature as a predictor of survival in breast cancer, N Engl J Med, 347, 1999, 10.1056/NEJMoa021967 van't Veer, 2002, Gene expression profiling predicts clinical outcome of breast cancer, Nature, 415, 530, 10.1038/415530a Paik, 2004, A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer, N Engl J Med, 351, 2817, 10.1056/NEJMoa041588 Konecny, 2003, Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer, J Natl Cancer Inst, 95, 142, 10.1093/jnci/95.2.142 Dawson, 2013, A new genome-driven integrated classification of breast cancer and its implications, EMBO J, 32, 617, 10.1038/emboj.2013.19 Henderson TO, 2014, Accelerated aging among cancer survivors: from pediatrics to geriatrics, Am Soc Clin Oncol Educ Book, e423, 10.14694/EdBook_AM.2014.34.e423 Berger, 2012, Cancer-related fatigue: implications for breast cancer survivors, Cancer, 118, 2261, 10.1002/cncr.27475 Demaria, 2017, Cellular senescence promotes adverse effects of chemotherapy and cancer relapse, Cancer Discov, 7, 165, 10.1158/2159-8290.CD-16-0241 Chang, 2016, Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice, Nat Med, 22, 78, 10.1038/nm.4010